Concepedia

Author

Petra Stegmaier

University Medical Center FreiburgORCID

Also Known As

P Stegmaier, P. Stegmaier, Petra Stegmaier

22

Publications

432

Citations

7

H-Index

16

Concepts

All Affiliations

University Medical Center FreiburgHeidelberg UniversityThe Ohio State University Wexner Medical CenterThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteUniversity Hospital Heidelberg
PS

About

Petra Stegmaier is an author at University Medical Center Freiburg specializing in radiation oncology, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

150

2

Health Sciences

2

2

117

3

Pathology

1

1

33

4

Surgical Oncology

1

1

100

5

Brachytherapy

1

1

100

Petra Stegmaier

×

6

Publications

416

Citations

6

H-Index

YearCitations

<i>SMARCA4</i> /BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

Erica H. Bell, Arup R. Chakraborty, Xiaokui Mo,

Clinical Cancer Research

2015

142

Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only

Hans Christian Rischke, Wolfgang Schultze‐Seemann, Gesche Wieser,

Strahlentherapie und Onkologie

2014

100

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra Seibold, Adam Webb, Miguel E. Aguado‐Barrera,

Radiotherapy and Oncology

2019

94

Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy

Nico Jehmlich, Petra Stegmaier, Claas Golatowski,

Journal of Proteomics

2015

33

A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy

Erica H. Bell, Simon Kirste, Jessica L. Fleming,

PLoS ONE

2015

30

Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck

Christiane Matuschek, Edwin Bölke, Claus Belka,

Strahlentherapie und Onkologie

2013

17

Page 1